More than 600 guests gathered for a night of fun, fashion and fundraising at CatWalk for CancerCare on Saturday, April 1, at the Burlington Marriott Hotel.
For years, glioblastoma, an aggressive form of brain cancer, has frustrated scientists and researchers. But while there is no known cure for this deadly disease, new, cutting-edge research may provide a life-prolonging option for glioblastoma patients and their families.
The National Accreditation Program for Breast Centers (NAPBC), a quality program of the American College of Surgeons (ACS), has granted three-year Accreditation to the Cancer Center at Lowell General Hospital.
Tufts Medical Center announced today that it has become the first center in New England to use the drug Jelmyto (UroGen Pharma, Inc.) for treatment of upper tract urothelial cancer (UTUC), a malignancy found in the kidney lining or the ureter, the thin tube connecting the bladder to the kidneys.
Tufts Medical Center announced today that Rachel J. Buchsbaum, MD, has been named Director of the Cancer Center, effective August 12, 2019. Dr. Buchsbaum, a nationally-recognized physician, researcher, educator and leader in breast cancer therapy, risk assessment and prevention, will steer the cancer programs at Tufts MC.